Retirement Systems of Alabama grew its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) by 0.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 332,712 shares of the biotechnology company’s stock after acquiring an additional 936 shares during the period. Retirement Systems of […]
SVB Leerink upgraded shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Rating) from a market perform rating to an outperform rating in a report published on Wednesday morning, PriceTargets.com reports. SVB Leerink also issued estimates for Arrowhead Pharmaceuticals’ Q2 2023 earnings at ($0.02) EPS, Q3 2023 earnings at ($0.02) EPS, Q4 2023 earnings at $0.33 EPS, […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) shares gapped up prior to trading on Wednesday . The stock had previously closed at $26.23, but opened at $27.81. Arrowhead Pharmaceuticals shares last traded at $29.58, with a volume of 470,763 shares trading hands. Wall Street Analysts Forecast Growth Several brokerages have issued reports on ARWR. SVB […]
Sanford C. Bernstein initiated coverage on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Rating) in a research note issued to investors on Tuesday, The Fly reports. The brokerage issued a market perform rating and a $27.00 price target on the biotechnology company’s stock. A number of other research analysts have also recently issued reports on […]